Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Telomerase inhibitors.

L K White1, W E Wright, J W Shay

  • 1Depts of Internal Medicine and Cell Biology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9039, USA.

Trends in Biotechnology
|February 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of human isogenic epithelial cell lines as a relevant tool to study colon carcinogenesis and interactions between genes and environment.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2026
Same author

The longitudinal behavioral effects of acute exposure to galactic cosmic radiation in female C57BL/6J mice: implications for deep space missions, female crews, and potential antioxidant countermeasures.

bioRxiv : the preprint server for biology·2024
Same author

Remote assessment of the Penn computerised neurocognitive battery in individuals with 22q11.2 deletion syndrome.

Journal of intellectual disability research : JIDR·2024
Same author

Retraction Note: OCT4 as a target of miR-34a stimulates p63 but inhibits p53 to promote human cell transformation.

Cell death & disease·2022
Same author

The COVID-19 pandemic's impact on worry and medical disruptions reported by individuals with chromosome 22q11.2 copy number variants and their caregivers.

Journal of intellectual disability research : JIDR·2022
Same author

Association among income loss, financial strain and depressive symptoms during COVID-19: evidence from two longitudinal studies.

medRxiv : the preprint server for health sciences·2020
Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026
Same journal

Acoustic cavitation-enhanced lymphatic trafficking of inhaled bacterial-sourced biohybrid vaccines for antitumor immunity.

Trends in biotechnology·2026
Same journal

Make uphill thermodynamics downhill in pathway design.

Trends in biotechnology·2026
Same journal

Engineering a capture-bioremediate-release microbial biofilm for simultaneous bioremediation of microplastics and adsorbed heavy metals.

Trends in biotechnology·2026
Same journal

Engineered bacterial biofilms for biotechnological applications.

Trends in biotechnology·2026
Same journal

Multiscale and programmable engineering of edible mushroom mycelium-based materials.

Trends in biotechnology·2026
See all related articles

Telomerase research is rapidly advancing, exploring enzyme inhibition as a novel cancer treatment. This review covers telomere and telomerase basics, current therapeutic approaches, and future prospects in oncology.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Telomeres protect chromosome ends, and their shortening is linked to cellular aging.
  • Telomerase is an enzyme that maintains telomere length, often reactivated in cancer cells.
  • Dysregulation of telomere maintenance is a hallmark of cancer, driving tumor progression.

Purpose of the Study:

  • To provide a foundational understanding of telomeres and telomerase.
  • To review current pre-clinical strategies for inhibiting telomerase activity.
  • To discuss the potential and challenges of telomerase inhibitors as anti-cancer therapeutics.

Main Methods:

  • Literature review of pre-clinical studies on telomerase inhibition.
  • Analysis of various therapeutic approaches targeting telomerase.

Related Experiment Videos

  • Discussion of future directions and potential clinical applications.

    • Main Results:

    • Multiple pre-clinical strategies for telomerase inhibition are under investigation.
    • Telomerase inhibitors show promise as a novel anti-cancer therapeutic modality.
    • Significant challenges remain in developing effective and safe telomerase-targeting drugs.

    Conclusions:

    • Telomerase inhibition represents a promising area for cancer therapy development.
    • Further research is needed to overcome challenges and translate pre-clinical findings into clinical success.
    • The future of telomerase-targeted cancer treatment holds significant potential for improving patient outcomes.